Literature DB >> 24096173

Ursodeoxycholic and deoxycholic acids: A good and a bad bile acid for intestinal calcium absorption.

Valeria Rodríguez1, María Rivoira, Ana Marchionatti, Adriana Pérez, Nori Tolosa de Talamoni.   

Abstract

The aim of this study was to investigate the effect of ursodeoxycholic acid (UDCA) on intestinal Ca(2+) absorption and to find out whether the inhibition of this process caused by NaDOC could be prevented by UDCA. Chicks were employed and divided into four groups: (a) controls, (b) treated with 10mM NaDOC, (c) treated with 60 μg UDCA/100g of b.w., and (d) treated with 10mM NaDOC and 60 μg UDCA/100g of b.w. UDCA enhanced intestinal Ca(2+) absorption, which was time and dose-dependent. UDCA avoided the inhibition of intestinal Ca(2+) absorption caused by NaDOC. Both bile acids altered protein and gene expression of molecules involved in the transcellular pathway of intestinal Ca(2+) absorption, but in the opposite way. UDCA aborted the oxidative stress produced by NaDOC in the intestine. UDCA and UDCA plus NaDOC increased vitamin D receptor protein expression. In conclusion, UDCA is a beneficial bile acid for intestinal Ca(2+) absorption. Contrarily, NaDOC inhibits the intestinal cation absorption through triggering oxidative stress. The use of UDCA in patients with cholestasis would be benefited because of the protective effect on the intestinal Ca(2+) absorption, avoiding the inhibition caused by hydrophobic bile acids and neutralizing the oxidative stress.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ca(2+)-ATPase; Calbindin D(28k); Intestinal Ca(2+) absorption; Na(+)/Ca(2+) exchanger; NaDOC; UDCA

Mesh:

Substances:

Year:  2013        PMID: 24096173     DOI: 10.1016/j.abb.2013.09.018

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

Review 1.  Molecular aspects of intestinal calcium absorption.

Authors:  Gabriela Diaz de Barboza; Solange Guizzardi; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China.

Authors:  Jinhua Gong; Lina He; Qinyuan Zou; Yangyang Zhao; Bangzhou Zhang; Rongmu Xia; Baolong Chen; Man Cao; Wenxiu Gong; Lin Lin; Xiujuan Lin; Guowei Wang; Muyun Guo; Jianquan He; Chuanxing Xiao; Jian Chen
Journal:  Microb Cell Fact       Date:  2022-07-11       Impact factor: 6.352

Review 3.  Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective.

Authors:  Yuan-Cheng Chen; Jonathan Greenbaum; Hui Shen; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

Review 4.  Gut microbial-derived short-chain fatty acids and bone: a potential role in fracture healing.

Authors:  A Wallimann; W Magrath; K Thompson; T Moriarty; R G Richards; C A Akdis; L O'Mahony; C J Hernandez
Journal:  Eur Cell Mater       Date:  2021-04-21       Impact factor: 4.325

Review 5.  Oxidative stress, antioxidants and intestinal calcium absorption.

Authors:  Gabriela Diaz de Barboza; Solange Guizzardi; Luciana Moine; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

6.  Alopecia after injection of ATX-101 for reduction of submental fat.

Authors:  Skylar Souyoul; Olivia Gioe; Ashley Emerson; Deirdre O'Boyle Hooper
Journal:  JAAD Case Rep       Date:  2017-05-23

Review 7.  Glutathione depleting drugs, antioxidants and intestinal calcium absorption.

Authors:  Luciana Moine; María Rivoira; Gabriela Díaz de Barboza; Adriana Pérez; Nori Tolosa de Talamoni
Journal:  World J Gastroenterol       Date:  2018-11-28       Impact factor: 5.742

8.  NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.

Authors:  Youcai Tang; Keith S Blomenkamp; Peter Fickert; Michael Trauner; Jeffrey H Teckman
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.